Immunotherapy of multiple sclerosis:: Where are we?: Where should we go?

被引:60
|
作者
Martin, R
Stürzebecher, CS
McFarland, HF
机构
[1] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[2] Schering AG, Clin Dev CNS, D-13342 Berlin, Germany
关键词
D O I
10.1038/ni0901-785
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Differences in multiple sclerosis patient's disease and their responses to standard drugs indicate that today's therapies need to be more individualized. It is proposed that gene expression profiling in conjunction with magnetic resonance imaging be used to optimize future treatment approaches.
引用
下载
收藏
页码:785 / 788
页数:4
相关论文
共 50 条